We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$40.4M +$1.12M +14,661 +3%
AllianceBernstein
52
AllianceBernstein
Tennessee
$40M -$6.65M -87,287 -15%
Swiss National Bank
53
Swiss National Bank
Switzerland
$37.8M +$2.19M +28,700 +7%
AI
54
Ariel Investments
Illinois
$37M -$22.3M -292,559 -39%
Charles Schwab
55
Charles Schwab
California
$36.2M +$580K +7,619 +2%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$34.6M +$45.7K +600 +0.1%
NIPH
57
NN Investment Partners Holdings
Netherlands
$34M +$9.76M +128,220 +44%
UBS AM
58
UBS AM
Illinois
$33.5M +$502K +6,589 +2%
EA
59
Emerald Acquisition
Washington
$32.8M +$30.7M +403,172 New
Sumitomo Mitsui Trust Group
60
Sumitomo Mitsui Trust Group
Japan
$32.8M -$387K -5,086 -1%
BlackRock
61
BlackRock
New York
$31.1M +$6.62M +86,920 +29%
SEI Investments
62
SEI Investments
Pennsylvania
$30.5M +$2.06M +27,087 +8%
TG
63
TCW Group
California
$29.2M -$1.43M -18,844 -5%
Fidelity International
64
Fidelity International
Bermuda
$28.7M +$6.69M +87,899 +33%
Morgan Stanley
65
Morgan Stanley
New York
$27.3M +$5.35M +70,282 +26%
Citadel Advisors
66
Citadel Advisors
Florida
$27.1M -$5.28M -69,382 -17%
Lord, Abbett & Co
67
Lord, Abbett & Co
New Jersey
$25.7M +$15.8M +207,900 +193%
SOMRS
68
State of Michigan Retirement System
Michigan
$25.1M +$19.8M +259,400 +527%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$25.1M -$415K -5,453 -2%
PTC
70
Philadelphia Trust Company
Pennsylvania
$25M -$4.73M -62,170 -17%
T. Rowe Price Associates
71
T. Rowe Price Associates
Maryland
$24.5M -$229M -3,012,930 -91%
MTB
72
Mizuho Trust & Banking
Japan
$24.1M +$6.3M +82,688 +39%
Mitsubishi UFJ Trust & Banking
73
Mitsubishi UFJ Trust & Banking
Japan
$23.7M +$24.8K +326 +0.1%
AAM
74
Aberdeen Asset Management
United Kingdom
$23M -$1.3M -17,029 -6%
PCM
75
Polaris Capital Management
Massachusetts
$22.6M +$91.4K +1,200 +0.4%
1 2
3
4 5

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.